Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Stoke Therapeutics, Inc. (STOK) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $21.63 Metrics
OS: 44.3 M -57 % ROE
Market cap: $957 M -225 % ROIC
Net cash: $231 M $5.23 per share
EV: $726 M

 
TTM Valuation
EBITDA
EBIT ($118) M
EPS ($2.57)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
Revenues12.40.00.00.00.03.6
            Revenue growth    -100.0% 
Cost of goods sold0.00.00.00.00.05.6
Gross profit12.40.00.00.00.0-2.0
            Gross margin100.0%    -54.4%
Research and development77.854.232.223.88.4 
General and administrative38.931.920.811.94.42.0
EBIT-104.4-86.1-53.0-35.7-12.8-5.6
            EBIT margin-841.2%    -154.4%
Pre-tax income-101.1-85.8-52.2-32.3-12.5-5.6
Income taxes0.00.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0%0.0%
Net income-101.1-85.8-52.2-32.3-12.5-5.6
            Net margin-814.7%    -154.5%
 
Diluted EPS($2.60)($2.34)($1.56)($1.80)($17.65)($8.29)
Shares outstanding (diluted)38.936.733.518.00.70.7
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy